PLEOPHARMA, INC. — Form D

PLEOPHARMA, INC. of PHOENIXVILLE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-08. The offering totals $36.2M, of which $6.2M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2025-08-08
Form: D
Accession: 0001801323-25-000003
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $36.2M
Amount sold: $6.2M
Remaining: $30.1M
Minimum investment: $50K
Investors: 9
Date of first sale: 2025-06-23
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-554209

Issuer

Name: PLEOPHARMA, INC.
CIK: 0001801323
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2020
Address: 518 KIMBERTON RD., PHOENIXVILLE, PA, 19460
Phone: (610) 937-2882

Officers, directors & promoters (18)

Name	Role	Location
Ginger Constantine	Director	Phoenixville, PA 19460, PA
Jay Constantine	Director	Phoenixville, PA 19460, PA
Robert Finizio	Director	Phoenixville, PA 19460, PA
Sarah Hassan	Director	Avon by the Sea, NJ
Timothy F McInerney	Director	Phoenixville, PA
Bisaro Paul	Director	Phoenixville, PA 19460, PA
Brij Sharma	Director	Phoenixville, PA 19460, PA
Thompson Tommy	Director	Phoenixville, PA 19460, PA
Daniel Alan Cartwright	Executive Officer	Phoenixville, PA 19460, PA
Ginger Constantine	Executive Officer	Phoenixville, PA 19460, PA
Jay Constantine	Executive Officer	Phoenixville, PA 19460, PA
Thomas F Poche	Executive Officer	Phoenixville, PA 19460, PA
Jay Constantine	Promoter	Phoenixville, PA 19460, PA
Robert Finizio	Promoter	Phoenixville, PA 19460, PA
Ginger Constantine	Promoter	Phoenixville, PA 19460, PA
THOMAS POCHE	Executive Officer	PHOENIXVILLE, PA
PAUL BISARO	Director	PHOENIXVILLE, PA
DANIEL CARTWRITGHT	Executive Officer	PHOENIXVILLE, PA

Other filings by this issuer (2)

Filed	Form	Offering	Sold
2022-05-06	D	$16.1M	$11.1M
2020-02-04	D	—	$130K

More